Hereditary iron and copper deposition: Diagnostics, pathogenesis and therapeutics

References

• Garrick MD, Nunez MT, Olivares M, Harris ED. Parallels and contrasts between iron and copper metabolism. Biometals 2003; 16: 1–8
   PubMed Web of Science ®Google Scholar
• Fox PL. The copper-iron chronicles: the story of an intimate relationship. Biometals 2003; 16: 9–40
   PubMed Web of Science ®Google Scholar
• Sharp P. The molecular basis of copper and iron interactions. Proc Nutr Soc 2004; 63: 563–9
   PubMed Web of Science ®Google Scholar
• Masini A, Ceccarelli D, Giovannini F, Montosi G, Garuti C, Pietrangelo A. Iron-induced oxidant stress leads to irreversible mitochondrial dysfunctions and fibrosis in the liver of chronic iron-dosed gerbils. The effect of silybin. J Bioenerg Biomembr 2000; 32: 175–82
   PubMed Web of Science ®Google Scholar
• Eaton JW, Qian MW. Molecular bases of cellular iron toxicity. Free Radic Biol Med 2002; 32: 833–40
   PubMed Web of Science ®Google Scholar
• Gaetke LM, Chow CK. Copper toxicity, oxidative stress, and antioxidant nutrients. Toxicology 2003; 189: 147–63
   PubMed Web of Science ®Google Scholar
• Krumschnabel G, Manzl C, Berger C, Hofer B. Oxidative stress, mitochondrial permeability transition, and cell death in Cu-exposed trout hepatocytes. Toxicol Appl Pharmacol 2005; 209: 62–73
   PubMed Web of Science ®Google Scholar
• Halliwell B, Gutteridge J. Free radicals in biology and medicine. Oxford University Press, Oxford 1999
   Google Scholar
• Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem 2005; 12: 1161–208
   PubMed Web of Science ®Google Scholar
• Kontoghiorghes GJ, Kolnagou A. Molecular factors and mechanisms affecting iron and other metal excretion or absorption in health and disease. The role of natural and synthetic chelators. Curr Med Chem 2005; 12: 2695–709
   PubMed Web of Science ®Google Scholar
• Mackenzie B, Garrick MD. Iron Imports. II. Iron uptake at the apical membrane in the intestine. Am J Physiol Gastrointest Liver Physiol 2005; 289: G981–6
   PubMed Web of Science ®Google Scholar
• Canonne-Hergaux F, Donovan A, Delaby C, Wang HJ, Gros P. Comparative studies of duodenal and macrophage ferroportin proteins. Am J Physiol Gastrointest Liver Physiol 2006; 290: G156–63
   PubMed Web of Science ®Google Scholar
• Shayeghi M, Latunde-Dada GO, Oakhill JS, Laftah AH, Takeuchi K, Halliday N, et al. Identification of an intestinal heme transporter. Cell 2005; 122: 789–801
   PubMed Web of Science ®Google Scholar
• Johnston KL, Johnson DM, Marks J, Srai SK, Debnam ES, Sharp PA. Non-haem iron transport in the rat proximal colon. Eur J Clin Invest 2006; 36: 35–40
   PubMed Web of Science ®Google Scholar
• Morgan EH, Oates PS. Mechanisms and regulation of intestinal iron absorption. Blood Cells Mol Dis 2002; 29: 384–99
   PubMed Web of Science ®Google Scholar
• Davies PS, Zhang AS, Anderson EL, Roy CN, Lampson MA, McGraw TE, et al. Evidence for the interaction of the hereditary haemochromatosis protein, HFE, with the transferrin receptor in endocytic compartments. Biochem J 2003; 373: 145–53
   PubMed Web of Science ®Google Scholar
• Drakesmith H, Sweetland E, Schimanski L, Edwards J, Cowley D, Ashraf M, et al. The hemochromatosis protein HFE inhibits iron export from macrophages. Proc Natl Acad Sci USA 2002; 99: 15602–7
   PubMed Web of Science ®Google Scholar
• Anderson GJ, Frazer DM, McKie AT, Vulpe CD, Smith A. Mechanisms of haem and non-haem iron absorption: Lessons from inherited disorders of iron metabolism. Biometals 2005; 18: 339–48
   PubMed Web of Science ®Google Scholar
• Ludwiczek S, Theurl I, Bahram S, Schumann K, Weiss G. Regulatory networks for the control of body iron homeostasis and their dysregulation in HFE mediated hemochromatosis. J Cell Physiol 2005; 204: 489–99
   PubMed Web of Science ®Google Scholar
• Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJ. Global prevalence of putative haemochromatosis mutations. J Med Genet 1997; 34: 275–8
   PubMed Web of Science ®Google Scholar
• Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nature Genet 1993; 5: 327–37
   PubMed Web of Science ®Google Scholar
• Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nature Genet 1993; 5: 344–50
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophys Res Commun 1993; 197: 271–7
   PubMed Web of Science ®Google Scholar
• Horn N, Tümer Z. Molecular genetics of intracellular copper transport. J Trace Elem Exp Med 1999; 12: 297–313
   Google Scholar
• Tanner MS. Role of copper in Indian childhood cirrhosis. Am J Clin Nutr 1998; 67: 1074S–81S
   PubMed Web of Science ®Google Scholar
• Müller T, Müller W, Feichtinger H. Idiopathic copper toxicosis. Am J Clin Nutr 1998; 67: 1082S–6S
   PubMed Web of Science ®Google Scholar
• Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene [published erratum appears in N Engl J Med 1999;341:1708]. N Engl J Med 1999; 341: 718–24
   PubMed Web of Science ®Google Scholar
• Hanson EH, Imperatore G, Burke W. HFE gene and hereditary hemochromatosis: a HuGE review. Am J Epidemiol 2001; 154: 193–206
   PubMed Web of Science ®Google Scholar
• Åsberg A, Hveem K, Thorstensen K, Ellekjær E, Kannelønning K, Fjøsne U, et al. Screening for hemochromatosis: high prevalence and low morbidity in an unselected population of 65,238 persons. Scand J Gastroenterol 2001; 36: 1108–15
   PubMed Web of Science ®Google Scholar
• von Kempis J. Arthropathy in hereditary hemochromatosis. Curr Opin Rheumatol 2001; 13: 80–3
   PubMed Web of Science ®Google Scholar
• Bothwell TH, MacPhail AP. Hereditary hemochromatosis: etiologic, pathologic, and clinical aspects. Semin Hematol 1998; 35: 55–71
   PubMed Web of Science ®Google Scholar
• Bailey EJ, Gardner BA. Hemochromatosis of the foot and ankle. Report of three cases and review of the literature. Clin Orthop 1998:108–15.
   PubMed Web of Science ®Google Scholar
• Niederau C, Fischer R, Pürschel A, Stremmel W, Häussinger D, Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107–19
   PubMed Web of Science ®Google Scholar
• Brandhagen DJ, Fairbanks VF Baldus W. Recognition and management of hereditary hemochromatosis. Am Fam Physician 2002;65:853–60, 65–6.
   PubMed Web of Science ®Google Scholar
• EASL International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485–504.
   PubMed Web of Science ®Google Scholar
• Olivarez L, Caggana M, Pass KA, Ferguson P, Brewer GJ. Estimate of the frequency of Wilson's disease in the US Caucasian population: a mutation analysis approach. Ann Hum Genet 2001; 65: 459–63
   PubMed Web of Science ®Google Scholar
• Brewer GJ, Yuzbasiyan-Gurkan V. Wilson's disease: an update, with emphasis on new approaches to treatment. Dig Dis 1989; 7: 178–93
   PubMed Web of Science ®Google Scholar
• Brewer G. Wilson's disease: a clinician's guide to recognition, diagnosis and management. Kluwer Academic Publishers, Boston 2001
   Google Scholar
• Saito T. Presenting symptoms and natural history of Wilson disease. Eur J Pediatr 1987; 146: 261–5
   PubMed Web of Science ®Google Scholar
• Kuan P. Cardiac Wilson's disease. Chest 1987; 91: 579–83
   PubMed Web of Science ®Google Scholar
• Aaseth J, Thomassen Y. Trace elements in liver diseases: oxidative stress and antioxidative protectants. In: Abdulla M, , et al. New aspects of trace element research. London: Smith-Gordon; 1999. pp 211–4.
   Google Scholar
• Brandao M, Oliveira JC, Bravo F, Reis J, Garrido I, Porto G. The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis. Haematologica 2005; 90: 31–7
   PubMed Web of Science ®Google Scholar
• Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 1996; 13: 399–408
   PubMed Web of Science ®Google Scholar
• Brittenham GM, Badman DG. Noninvasive measurement of iron: Report of an NIDDK workshop. Blood 2003; 101: 15–9
   PubMed Web of Science ®Google Scholar
• Gandon Y, Olivié D, Guyader D, Aubé C, Oberti F, Sebille V, et al. Non-invasive assessment of hepatic iron stores by MRI. Lancet 2004; 363: 357–62
   PubMed Web of Science ®Google Scholar
• McCullen MA, Crawford DHG, Hickman PE. Screening for hemochromatosis. Clin Chim Acta 2002; 315: 169–86
   PubMed Web of Science ®Google Scholar
• Tavill AS. Clinical implications of the hemochromatosis gene. N Engl J Med 1999; 341: 755–7
   PubMed Web of Science ®Google Scholar
• Roueché B. Live and let live. The medical detectives, B Roueché. Times Books, New York 1980; 345–60
   Google Scholar
• Gu M, Cooper JM, Butler P, Walker AP, Mistry PK, Dooley JS, et al. Oxidative-phosphorylation defects in liver of patients with Wilson's disease. Lancet 2000; 356: 469–74
   PubMed Web of Science ®Google Scholar
• Gitlin JD. Aceruloplasminemia. Pediatr Res 1998; 44: 271–6
   PubMed Web of Science ®Google Scholar
• Ponka P. Iron metabolism: physiology and pathophysiology. J Trace Elem Exp Med 2000; 13: 73–83
   Google Scholar
• Pufahl RA, Singer CP, Peariso KL, Lin S-J, Schmidt PJ, Fahrni CJ, et al. Metal ion chaperone function of the soluble Cu(I) receptor Atx1. Science 1997; 278: 853–6
   PubMed Web of Science ®Google Scholar
• Milman N, Pedersen P. Evidence that the Cys282Tyr mutation of the HFE gene originated from a population in Southern Scandinavia and spread with the Vikings. Clin Genet 2003; 64: 36–47
   PubMed Web of Science ®Google Scholar
• Pietrangelo A. Hereditary hemochromatosis: a new look at an old disease. N Engl J Med 2004; 350: 2383–97
   PubMed Web of Science ®Google Scholar
• Roetto A, Totaro A, Cazzola M, Cicilano M, Bosio S, D'Ascola G, et al. Juvenile hemochromatosis locus maps to chromosome 1q. Am J Hum Genet 1999; 64: 1388–93
   PubMed Web of Science ®Google Scholar
• Camaschella C, Roetto A, Cali A, De Gobbi M, Garozzo G, Carella M, et al. The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nature Genet 2000; 25: 14–5
   PubMed Web of Science ®Google Scholar
• Cullen LM, Anderson GJ, Ramm GA, Jazwinska EC, Powell LW. Genetics of hemochromatosis. Annu Rev Med 1999; 50: 87–98
   PubMed Web of Science ®Google Scholar
• Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N, , et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Natl Acad Sci USA 1998;95:1472–7.
   PubMed Web of Science ®Google Scholar
• Zhou XY, Tomatsu S, Fleming RE, Parkkila S, Waheed A, Jiang J, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492–7
   PubMed Web of Science ®Google Scholar
• Parkkila S, Waheed A, Britton RS, Feder JN, Tsuchihashi Z, Schatzman RC, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA 1997; 94: 2534–9
   PubMed Web of Science ®Google Scholar
• Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, et al. Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 1997; 61: 317–28
   PubMed Web of Science ®Google Scholar
• Mercer JFB. The molecular basis of copper-transport diseases. Trend Mol Med 2001; 7: 64–9
   PubMed Web of Science ®Google Scholar
• Menkes JH. Menkes disease and Wilson disease: two sides of the same copper coin. Part I: Menkes disease. Eur J Paediatr Neurol 1999; 3: 147–58
   PubMedGoogle Scholar
• Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Ann Intern Med 1998; 129: 932–9
   PubMed Web of Science ®Google Scholar
• Kontoghiorghes GJ. Comparative efficacy and toxicity of desferrioxamine, deferiprone and other iron and aluminum chelating drugs. Toxicol Lett 1995; 80: 1–18
   PubMed Web of Science ®Google Scholar
• Catsch A, Hartmuth-Hoene A-E. Pharmacology and therapeutic applications of agents used in heavy metal poisoning. Pharmacol Ther [A] 1976; 1: 1–118
   Web of Science ®Google Scholar
• Kontoghiorghes GJ, Eracleous E, Economides C, Kolnagou A. Advances in iron overload therapies. Prospects for effective use of deferiprone (L1), deferoxamine, the new experimental chelators ICL670, GT56-252, L1NAII and their combinations. Curr Med Chem 2005; 12: 2663–81
   PubMed Web of Science ®Google Scholar
• Neufeld EJ. Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions. Blood 2006; 107: 3436–41
   PubMed Web of Science ®Google Scholar
• Walshe JM. Penicillamine, a new oral therapy for Wilsons disease. Am J Med 1956; 21: 487–95
   PubMed Web of Science ®Google Scholar
• Planas-Bohne F. Metabolism and pharmacokinetics of penicillamine in rats: an overview. J Rheumatol 1981; 8 Suppl 7: 35–40
   Web of Science ®Google Scholar
• Jellum E, Munthe E, Guldal G, Aaseth J. Gold and thiol compounds in the treatment of rheumatoid arthritis: Excretory fate and tissue distribution of thiomalate in relation to gold after administration of myocrisin (auro-thiomalate). Scand J Rheumatol 1979; Suppl 28: 28–36
   Google Scholar
• Walshe JM. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride. Q J Med 1973; 42: 441–52
   PubMedGoogle Scholar
• Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;i:643–7.
   Google Scholar
• Kodama H, Murata Y, Iitsuka T, Abe T. Metabolism of administered triethylene tetramine dihydrochloride in humans. Life Sci 1997; 61: 899–907
   PubMed Web of Science ®Google Scholar
• Yanagisawa T, Maemura S, Sasaki H, Endo T, Okada M, East PW, et al. Subacute and chronic toxicity studies of triehylenetetramine dihydrochloride (TJA-250) by oral administration to F-344 rats. J Toxicol Sci 1998; 23 Suppl 4: 619–42
   PubMedGoogle Scholar
• Walshe JM. Treatment of Wilson's disease: the historical background. Q J Med 1996; 89: 53–5
   Google Scholar
• Andersen O. Principles and recent developments in chelation treatment of metal intoxication. Chem Rev 1999; 99: 2683–710
   PubMed Web of Science ®Google Scholar
• Ren M, Yang R. Clinical curative effects of dimercaptosuccinic acid on hepatolenticular degeneration and the impact of DMSA on biliary trace elements. Chin Med J 1997; 110: 694–7
   PubMed Web of Science ®Google Scholar
• Hoogenraad TU, Van den Hamer CJA, Koevoet R, De Ruyter Korver EGWM. Oral zinc in Wilson's disease. Lancet 1978; ii: 1262
   Google Scholar
• Brewer GJ. Zinc acetate for the treatment of Wilson's disease. Expert Opin Pharmacother 2001; 2: 1473–7
   PubMedGoogle Scholar
• Hoogenraad TU. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice. Brain Dev 2006; 28: 141–6
   PubMed Web of Science ®Google Scholar